These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16704740)

  • 1. Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis.
    Martarelli D; Catalano A; Procopio A; Orecchia S; Libener R; Santoni G
    BMC Cancer; 2006 May; 6():130. PubMed ID: 16704740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical course of human epithelial-type malignant pleural mesothelioma replicated in an orthotopic-transplant nude mouse model.
    Colt HG; Astoul P; Wang X; Yi ES; Boutin C; Hoffman RM
    Anticancer Res; 1996; 16(2):633-9. PubMed ID: 8687108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.
    Ikuta K; Yano S; Trung VT; Hanibuchi M; Goto H; Li Q; Wang W; Yamada T; Ogino H; Kakiuchi S; Uehara H; Sekido Y; Uenaka T; Nishioka Y; Sone S
    Clin Cancer Res; 2009 Dec; 15(23):7229-37. PubMed ID: 19934291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice.
    Li Q; Yano S; Ogino H; Wang W; Uehara H; Nishioka Y; Sone S
    Clin Cancer Res; 2007 Oct; 13(19):5918-25. PubMed ID: 17908988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and preliminary characterization of human malignant mesothelioma cell lines.
    de Cupis A; Pirani P; Favoni RE
    Monaldi Arch Chest Dis; 1998 Apr; 53(2):188-92. PubMed ID: 9689807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of interleukin-8 reduces human malignant pleural mesothelioma propagation in nude mouse model.
    Galffy G; Mohammed KA; Nasreen N; Ward MJ; Antony VB
    Oncol Res; 1999; 11(4):187-94. PubMed ID: 10566617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An experimental model of pleural adenocarcinoma constructed by the implantation of intact human neoplastic tissue in the nude mouse. The prognostic value of a lesion of the visceral pleura].
    Astoul P; Boutin C; Hoffman RM
    Rev Mal Respir; 1995; 12(3):267-73. PubMed ID: 7638423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
    Wagner D; Bourne PA; Yang Q; Goldman BI; Lewis JS; Xu H
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):301-7. PubMed ID: 18301236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A patient-like human malignant pleural mesothelioma nude-mouse model.
    Astoul P; Wang X; Colt H; Boutin C; Hoffman R
    Oncol Rep; 1996 May; 3(3):483-7. PubMed ID: 21594397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model.
    Van TT; Hanibuchi M; Goto H; Kuramoto T; Yukishige S; Kakiuchi S; Sato S; Sakaguchi S; Dat le T; Nishioka Y; Akiyama S; Sone S
    Respirology; 2012 Aug; 17(6):984-90. PubMed ID: 22574723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy.
    Watanabe Y; Kojima T; Kagawa S; Uno F; Hashimoto Y; Kyo S; Mizuguchi H; Tanaka N; Kawamura H; Ichimaru D; Urata Y; Fujiwara T
    Oncogene; 2010 Feb; 29(8):1145-54. PubMed ID: 19935710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant pleural mesothelioma: clinicopathology of 16 extrapleural pneumonectomy patients with special reference to early stage features.
    Hiroshima K; Yusa T; Kameya T; Ito I; Kaneko K; Kadoyama C; Kishi H; Saitoh Y; Ozaki D; Itami M; Iwata T; Iyoda A; Kawai T; Yoshino I; Nakatani Y
    Pathol Int; 2009 Aug; 59(8):537-45. PubMed ID: 19627537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Patient-like" nude mouse metastatic model of advanced human pleural cancer.
    Astoul P; Colt HG; Wang X; Boutin C; Hoffman RM
    J Cell Biochem; 1994 Sep; 56(1):9-15. PubMed ID: 7806595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of malignant pleural mesothelioma with gastrointestinal metastases which were diagnosed by endoscopic biopsy].
    Terashita S; Hirano K; Hirai T; Narabayashi T; Hara Y; Mori H; Endo K; Hirabayashi M
    Nihon Kokyuki Gakkai Zasshi; 2009 Feb; 47(2):133-8. PubMed ID: 19260537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting alpha7-nicotinic receptor for the treatment of pleural mesothelioma.
    Catassi A; Paleari L; Servent D; Sessa F; Dominioni L; Ognio E; Cilli M; Vacca P; Mingari M; Gaudino G; Bertino P; Paolucci M; Calcaterra A; Cesario A; Granone P; Costa R; Ciarlo M; Alama A; Russo P
    Eur J Cancer; 2008 Oct; 44(15):2296-311. PubMed ID: 18722110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs).
    Ishii H; Yazawa T; Sato H; Suzuki T; Ikeda M; Hayashi Y; Takanashi Y; Kitamura H
    Lung Cancer; 2004 Sep; 45(3):325-37. PubMed ID: 15301873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a human malignant mesothelioma cell line (H-MESO-1): a biphasic solid and ascitic tumor model.
    Reale FR; Griffin TW; Compton JM; Graham S; Townes PL; Bogden A
    Cancer Res; 1987 Jun; 47(12):3199-205. PubMed ID: 3555770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localised malignant pleural mesothelioma: a separate clinical entity requiring aggressive local surgery.
    Nakas A; Martin-Ucar AE; Edwards JG; Waller DA
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):303-6. PubMed ID: 18155556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma.
    Ohta Y; Shridhar V; Kalemkerian GP; Bright RK; Watanabe Y; Pass HI
    Cancer; 1999 Jun; 85(12):2570-6. PubMed ID: 10375104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapleural Adenoviral-mediated Endothelial Cell Protein C Receptor Gene Transfer Suppresses the Progression of Malignant Pleural Mesothelioma in a Mouse Model.
    Keshava S; Rao LV; Pendurthi UR
    Sci Rep; 2016 Nov; 6():36829. PubMed ID: 27833109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.